Cargando…
Novel MR imaging contrast agents for cancer detection
BACKGROUND: Novel potential MR imaging contrast agents Gd-tetra-carboranylmethoxyphenyl-porphyrin (Gd-TCP), Gd-hematoporphyrin (Gd-H), Gd-DTPA-9.2.27 against melanoma, Gd-DTPA-WM53 against leukemia and Gd-DTPA-C595 against breast cancer cells were synthesized and applied to mice with different human...
Autor principal: | Shahbazi-Gahrouei, Daryoush |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications Pvt Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129053/ https://www.ncbi.nlm.nih.gov/pubmed/21772875 |
Ejemplares similares
-
Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2013) -
Magnetic Iron Oxide Nanoparticles as T(2) MR Imaging Contrast Agent for Detection of Breast Cancer (MCF-7) Cell
por: Moradi Khaniabadi, Pegah, et al.
Publicado: (2017) -
Assessment of Manganese-Zinc Ferrite Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent for the Detection of 4T1 Breast Cancer Cells
por: Sobhani, Tayebe, et al.
Publicado: (2019) -
Detection of MUC1-Expressing Ovarian Cancer by C595 Monoclonal Antibody-Conjugated SPIONs Using MR Imaging
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2013) -
Aptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer
por: Keshtkar, Mohammad, et al.
Publicado: (2016)